ロード中...

Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

OBJECTIVE: Thiazolidinediones reduce hepatic steatosis and increase HDL cholesterol levels. In mice with human-like lipoprotein metabolism (APOE*3-Leiden.CETP transgenic mice), a decrease in hepatic triglyceride content is associated with a decrease in plasma cholesteryl ester transfer protein (CETP...

詳細記述

保存先:
書誌詳細
主要な著者: Jonker, Jacqueline T., Wang, Yanan, de Haan, Willeke, Diamant, Michaela, Rijzewijk, Luuk J., van der Meer, Rutger W., Lamb, Hildo J., Tamsma, Jouke T., de Roos, Albert, Romijn, Johannes A., Rensen, Patrick C.N., Smit, Johannes W.A.
フォーマット: Artigo
言語:Inglês
出版事項: American Diabetes Association 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2890371/
https://ncbi.nlm.nih.gov/pubmed/20150294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc09-1935
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!